c-Myb increases resistance of colon carcinoma cells to cisplatin by activation of MAPKp38δ and JNK/c-Jun signaling pathways

Logo poskytovatele

Varování

Publikace nespadá pod Filozofickou fakultu, ale pod Přírodovědeckou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

PEKARČÍKOVÁ Lucie KNOPFOVÁ Lucia ŠMARDA Jan

Rok publikování 2013
Druh Konferenční abstrakty
Fakulta / Pracoviště MU

Přírodovědecká fakulta

Citace
Popis c-Myb is a transcription factor playing essential role in control of proliferation, differentiation and apoptosis of epithelial cells. Its malfunction has been associated with various tumors. Patients with colorectal carcinomas (CRC) exhibiting upregulated c-Myb expression have poor prognosis. The aim of this study was to clarify the role of c-Myb in control of the cell death/survival of colorectal carcinoma cells treated with cytotoxic agents. Our results show that the c-Myb protein reduced sensitivity of colorectal carcinoma cells to cisplatin and doxorubicin. We identified the downstream effectors mediating the effects c-Myb on cell viability - MAPKp38 and c-Jun kinases. Selective inhibitors of these kinases were used to prove the potential link between c-Myb upregulation and improved survival of colorectal cells exposed to cisplatin. Using a panel of p38 inhibitors we identified MAPKp38delta isoform (MAPK13) as a key molecule in mediating this effect. In this work, we present the possibility of a novel c-Myb-p38delta/JNK signal axis mediating increased resistance of colorectal cells to cytotoxic agents.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.